|
Re: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
6
|
Resverlogix Corp.
|
May 09, 2022 08:09AM
|
|
Re: RVX gets Breakthrough Therapy Designation!!!
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 09:06AM
|
|
Re: What's the deal with Zenith?
|
6
|
Zenith Epigenetics
|
Jun 24, 2023 12:56PM
|
|
Re: RVX is
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 10:11AM
|
|
Re: ask Don?
|
6
|
Resverlogix Corp.
|
Oct 29, 2019 11:59AM
|
|
Re: Thursday's presenstation bounce short lived....
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 03:58PM
|
|
Re: What's nice about April
|
6
|
Resverlogix Corp.
|
Apr 05, 2019 08:39AM
|
|
Re: 3.25-3.50 holding well
|
6
|
Resverlogix Corp.
|
May 27, 2019 10:45AM
|
|
Re: Thrown in the towel?
|
6
|
Resverlogix Corp.
|
Aug 04, 2022 03:03PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
6
|
Resverlogix Corp.
|
Jun 30, 2019 09:47AM
|
|
Re: Rules of thumb and broken thumbs...
|
6
|
Resverlogix Corp.
|
Sep 29, 2020 12:07PM
|
|
Banging the Crestor drum ...
|
6
|
Resverlogix Corp.
|
Oct 01, 2019 09:38AM
|
|
Re: Close competitor…
|
6
|
Resverlogix Corp.
|
Oct 21, 2021 09:20AM
|
|
Re: Symptoms, causes, and treatment of chronic kidney disease
|
6
|
Resverlogix Corp.
|
Mar 02, 2020 09:23AM
|
|
Re: RVX End Game
|
6
|
Resverlogix Corp.
|
Jul 15, 2020 10:29PM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
6
|
Resverlogix Corp.
|
Jul 27, 2020 12:22PM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
6
|
Resverlogix Corp.
|
Aug 29, 2019 10:16AM
|
|
Re: No mention of efficacy again...
|
6
|
Resverlogix Corp.
|
Mar 29, 2019 03:04PM
|
|
Re: 47 Taken out by Gilead for $4.9 billion
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 08:06AM
|
|
Re: Ownership Update
|
6
|
Resverlogix Corp.
|
Feb 20, 2023 11:42AM
|
